Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)
India
· Delayed Price · Currency is INR 26.08
-0.07 (-0.27%)
At close: Jun 5, 2025
BOM:524663 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2014 - 2018 |
| Cash & Equivalents | 12.86 | 46.43 | 12.27 | 9.85 | 4.08 | Upgrade
|
| Short-Term Investments | - | - | - | - | 21.01 | Upgrade
|
| Cash & Short-Term Investments | 12.86 | 46.43 | 12.27 | 9.85 | 25.09 | Upgrade
|
| Cash Growth | -72.30% | 278.40% | 24.57% | -60.73% | -82.85% | Upgrade
|
| Accounts Receivable | 138.76 | 11.33 | 0.12 | 188.01 | 729.72 | Upgrade
|
| Other Receivables | 39.4 | 32.43 | 29.23 | - | 4.52 | Upgrade
|
| Receivables | 178.16 | 43.76 | 29.35 | 188.01 | 734.24 | Upgrade
|
| Inventory | 14.22 | 362.5 | 134.9 | 517.19 | 144.39 | Upgrade
|
| Prepaid Expenses | 0.12 | 1.68 | - | 0.01 | 0.04 | Upgrade
|
| Other Current Assets | 152.67 | 199.92 | 163.02 | 215.14 | 83.61 | Upgrade
|
| Total Current Assets | 358.03 | 654.29 | 339.54 | 930.2 | 987.35 | Upgrade
|
| Property, Plant & Equipment | 1,157 | 1,160 | 361.28 | 46.84 | 49.21 | Upgrade
|
| Long-Term Deferred Tax Assets | 266.55 | 210.26 | 200.93 | 139.98 | 100.09 | Upgrade
|
| Other Long-Term Assets | 104.43 | 102.93 | 138.11 | 151.28 | 112.96 | Upgrade
|
| Total Assets | 1,886 | 2,127 | 1,040 | 1,268 | 1,250 | Upgrade
|
| Accounts Payable | 10.31 | 8.69 | 147.93 | 435.32 | 441.84 | Upgrade
|
| Accrued Expenses | 63.6 | 55.52 | 46.42 | 16.04 | 10.08 | Upgrade
|
| Short-Term Debt | 702.25 | 778.85 | 272.93 | 30.38 | 322.22 | Upgrade
|
| Current Unearned Revenue | 90.66 | 112 | 93.83 | 119.59 | 70.03 | Upgrade
|
| Other Current Liabilities | 73.6 | 57.58 | 79.8 | 405.75 | 40.58 | Upgrade
|
| Total Current Liabilities | 940.42 | 1,013 | 640.91 | 1,007 | 884.75 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 4.8 | Upgrade
|
| Other Long-Term Liabilities | 0.72 | 0.72 | 0.72 | 1.35 | - | Upgrade
|
| Total Liabilities | 1,004 | 1,074 | 699.45 | 1,064 | 942.83 | Upgrade
|
| Common Stock | 431.8 | 431.8 | 431.8 | 431.8 | 431.8 | Upgrade
|
| Retained Earnings | -662.11 | -495.73 | -408.19 | -227.14 | -125.03 | Upgrade
|
| Comprehensive Income & Other | 1,112 | 1,117 | 316.8 | 0.08 | - | Upgrade
|
| Shareholders' Equity | 882.14 | 1,054 | 340.41 | 204.74 | 306.77 | Upgrade
|
| Total Liabilities & Equity | 1,886 | 2,127 | 1,040 | 1,268 | 1,250 | Upgrade
|
| Total Debt | 702.25 | 778.85 | 272.93 | 30.38 | 322.22 | Upgrade
|
| Net Cash (Debt) | -689.39 | -732.42 | -260.66 | -20.53 | -297.14 | Upgrade
|
| Net Cash Per Share | -15.97 | -16.96 | -6.04 | -0.48 | -6.88 | Upgrade
|
| Filing Date Shares Outstanding | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | Upgrade
|
| Total Common Shares Outstanding | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | Upgrade
|
| Working Capital | -582.4 | -358.35 | -301.37 | -76.87 | 102.6 | Upgrade
|
| Book Value Per Share | 20.43 | 24.40 | 7.88 | 4.74 | 7.10 | Upgrade
|
| Tangible Book Value | 882.14 | 1,054 | 340.41 | 204.74 | 306.77 | Upgrade
|
| Tangible Book Value Per Share | 20.43 | 24.40 | 7.88 | 4.74 | 7.10 | Upgrade
|
| Land | 1,123 | 1,128 | 8.35 | 8.35 | 8.35 | Upgrade
|
| Buildings | 123.68 | 123.68 | 123.68 | 123.68 | 19.82 | Upgrade
|
| Machinery | 323.32 | 323.32 | 323.12 | 323.32 | 31.44 | Upgrade
|
| Construction In Progress | - | - | 319 | 2.19 | 2.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.